NCT00083538View on ClinicalTrials.gov

Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Multiple Myeloma
Interventions
DRUG

Dexamethasone

DRUG

Thalidomide

DRUG

Cisplatinum

DRUG

Adriamycin

DRUG

Cyclophosphamide

DRUG

Etoposide

Trial Locations (1)

72205

University of Arkansas for Medical Sciences/MIRT, Little Rock

All Listed Sponsors
lead

University of Arkansas

OTHER

NCT00083538 - Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally | Biotech Hunter | Biotech Hunter